Claudia Gonzalo‐Consuegra

Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis

Loreto Martínez‐González, Claudia Gonzalo‐Consuegra, Marta Gómez‐Almería et al. · International Journal of Molecular Sciences · 2021 · 63 citations · Full text

Life Sciences, Neurology, Pharmacology +16

Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis

Elisa Rojas‐Prats, Loreto Martínez‐González, Claudia Gonzalo‐Consuegra et al. · European Journal of Medicinal Chemistry · 2020 · 48 citations · Full text

Life Sciences, Neurology, Neuroscience +13

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

Vanesa Nozal, Loreto Martínez‐González, Marta Gómez‐Almería et al. · Journal of Medicinal Chemistry · 2022 · 43 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice

Sonia Burgaz, Concepción García, María Gómez‐Cañas et al. · Molecular and Cellular Neuroscience · 2020 · 32 citations

Medicine, Neuroscience, Pharmacology +14

Δ⁹‐Tetrahydrocannabinolic acid alleviates collagen‐induced arthritis: Role of PPARγ and CB₁ receptors

Belén Palomares, Martín Garrido‐Rodríguez, Claudia Gonzalo‐Consuegra et al. · British Journal of Pharmacology · 2020 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17